Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Ford

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
The Journal of Antibiotics|March 1, 1984
A simple system for studying antibiotic binding to leukocytesG D Gray, G M Ohlmann, C W Ford, et al.
Expert Opinion on Investigational Drugs|February 1, 1997
Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolidG E Zurenko, C W Ford, D K Hutchinson, et al.
American Journal of Veterinary Research|July 1, 1987
Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in miceR J Yancey, M L Kinney, B J Roberts, et al.
Current Opinion in Pharmacology|January 5, 2002
Oxazolidinones: a new class of antibacterialsG E Zurenko, J K Gibson, D L Shinabarger, et al.
Trends in Microbiology|May 1, 1997
Oxazolidinones: new antibacterial agentsC W Ford, J C Hamel, D Stapert, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2000
MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animalsT L Bowersock, S A Salmon, E S Portis, et al.
The Journal of Antimicrobial Chemotherapy|February 27, 2001
Efficacy of linezolid in a staphylococcal endocarditis rabbit modelM P Oramas-Shirey, L V Buchanan, C L Dileto-Fang, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2001
Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureusC F Dailey, C L Dileto-Fang, L V Buchanan, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infectionsC W Ford, J C Hamel, D M Wilson, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and antibacterial activity of [6,5,5] and [6,6,5] tricyclic fused oxazolidinonesD M Gleave, S J Brickner, P R Manninen, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The Journal of Antibiotics|March 1, 1984
A simple system for studying antibiotic binding to leukocytesG D Gray, G M Ohlmann, C W Ford, et al.
Expert Opinion on Investigational Drugs|February 1, 1997
Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolidG E Zurenko, C W Ford, D K Hutchinson, et al.
American Journal of Veterinary Research|July 1, 1987
Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in miceR J Yancey, M L Kinney, B J Roberts, et al.
Current Opinion in Pharmacology|January 5, 2002
Oxazolidinones: a new class of antibacterialsG E Zurenko, J K Gibson, D L Shinabarger, et al.
Trends in Microbiology|May 1, 1997
Oxazolidinones: new antibacterial agentsC W Ford, J C Hamel, D Stapert, et al.
Antimicrobial Agents and Chemotherapy|April 19, 2000
MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animalsT L Bowersock, S A Salmon, E S Portis, et al.
The Journal of Antimicrobial Chemotherapy|February 27, 2001
Efficacy of linezolid in a staphylococcal endocarditis rabbit modelM P Oramas-Shirey, L V Buchanan, C L Dileto-Fang, et al.
Antimicrobial Agents and Chemotherapy|July 14, 2001
Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureusC F Dailey, C L Dileto-Fang, L V Buchanan, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
In vivo activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents, against experimental bacterial infectionsC W Ford, J C Hamel, D M Wilson, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and antibacterial activity of [6,5,5] and [6,6,5] tricyclic fused oxazolidinonesD M Gleave, S J Brickner, P R Manninen, et al.
Pageof 4